UK Markets closed
Explore/

The fight against COVID19

The fight against COVID19

23.66k followers • 14 symbols Watchlist by TREA

Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.

Curated by TREA

TREA analyses over 100 million data points, interactions, relationships on company research and development activities, allowing investors to quickly gain insight without having to go through complex regulatory filings. Primary data sources include: US FDA (US Food and Drug Administration), US NIH (US National Institutes of Health), USPTO (US Patent and Trademark Office). The search parameters for generating this watchlist were (1) Above sector average Innovation Index score, (2) IP history of at least 5 years (3) COVID19 (4) 2019-nCov (5) SARS-CoV-2, among others.

Performance

WatchlistChange today1-month return1-year returnTotal return
The fight against COVID19+2.07%---
^GSPC+1.44%+3.21%-10.33%+4318.61%

14 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
JNJJohnson & Johnson155+1.57+1.02%16:00 GMT-49.25M8.24M405.24B
ABBVAbbVie Inc.159.37+1.45+0.92%16:03 GMT-44.96M6.34M281.84B
PFEPfizer Inc.40.8+0.42+1.04%16:03 GMT-422.83M23.08M229.02B
SNYSanofi54.42+0.45+0.83%16:00 GMT-42.03M2.02M136.34B
GILDGilead Sciences, Inc.82.97+1.52+1.87%16:00 GMT-47.14M6.25M104.06B
REGNRegeneron Pharmaceuticals, Inc.821.67+10.17+1.25%16:00 GMT-4866.17k650.92k89.48B
GSKGlaxoSmithKline plc35.58+0.31+0.88%16:00 GMT-42.79M3.66M72.84B
MRNAModerna, Inc.153.58+6.14+4.16%16:00 GMT-43.78M3.59M59.00B
TAKTakeda Pharmaceutical Company Limited16.48+0.13+0.80%16:00 GMT-41.67M2.68M51.24B
BNTXBioNTech SE124.57+2.00+1.63%16:00 GMT-4803.62k686.76k30.23B
VIRVir Biotechnology, Inc.23.27+0.27+1.17%16:00 GMT-4779.89k1.02M3.10B
NVAXNovavax, Inc.6.93+0.34+5.16%16:00 GMT-45.23M6.52M589.08M
INOInovio Pharmaceuticals, Inc.0.82+0.03+3.51%16:00 GMT-45.84M4.50M204.58M
  • Motley Fool

    Could This Drug News Lift AbbVie's Stock?

    Consider AbbVie's (NYSE: ABBV) crown jewel drug, Humira, which hauled in $21.2 billion in revenue in 2022. The good news is that AbbVie knew this day would come and has been preparing. SLE is an autoimmune disease that affects multiple organs of the body.

  • Simply Wall St.

    AbbVie Inc. (NYSE:ABBV) insiders sold US$6.3m worth of stock, possibly signalling a downtrend

    In the last year, many AbbVie Inc. ( NYSE:ABBV ) insiders sold a substantial stake in the company which may have...

  • Motley Fool

    3 Surprisingly Underrated Stocks to Buy in April

    Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) as opportunities that especially stand out. Prosper Junior Bakiny (Axsome Therapeutics): Last year, Axsome Therapeutics' share price doubled, partly due to the FDA approving its depression medicine Auvelity for use. The company's stock is down by 19% since the start of the year.